Clinical Trials Logo

Thyroid Cancer clinical trials

View clinical trials related to Thyroid Cancer.

Filter by:

NCT ID: NCT04320901 Recruiting - Thyroid Cancer Clinical Trials

Energy Device Study in Transoral Endoscopic Thyroidectomy

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

Open label randomized controlled study, for Harmonic versus Ligasure in transoral endoscopic thyroid surgery.

NCT ID: NCT04312087 Recruiting - Thyroid Cancer Clinical Trials

Lateral Neck Lymph Node Mapping in Thyroid Cancer

Start date: August 1, 2016
Phase: N/A
Study type: Interventional

This study includes papillary thyroid cancer patients who have unpalpable lateral neck lymph nodes but suspicious on ultrasound and/or CT. Carbon nanoparticles is used as the tracer for lateral neck lymph node mapping.

NCT ID: NCT04309136 Active, not recruiting - Thyroid Cancer Clinical Trials

Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

Start date: June 1, 2019
Phase: Phase 2
Study type: Interventional

To determine the efficacy and safety of Anlotinib in patients of locally advanced thyroid cancer in the neoadjuvant setting.

NCT ID: NCT04290663 Recruiting - Thyroid Cancer Clinical Trials

Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

INTERMEDIATE
Start date: March 2, 2020
Phase: Phase 3
Study type: Interventional

This trial is comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy

NCT ID: NCT04285476 Recruiting - Thyroid Cancer Clinical Trials

Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type

PREDICYTHY
Start date: June 17, 2021
Phase: N/A
Study type: Interventional

The aim is to validate a signature of microRNA (micro Ribonucleic acid) based in a first exploratory study allowing the stratification of the cytologies of indeterminate type and to study and select others. In a first step, the teams will focus on standardising the pre-analytical stages and defining a threshold of positivity. The results of microRNA signature on a cohort of 70 patients will be compared with the ultrasound and then histological data of the resection specimen.

NCT ID: NCT04281875 Completed - Thyroid Cancer Clinical Trials

Assessing Benefits of NIRAF Detection for Identifying Parathyroid Glands During Total Thyroidectomy.

NIRAF
Start date: March 16, 2020
Phase: N/A
Study type: Interventional

This study describes a single center, randomized, single-blinded clinical trial to assess the clinical benefits of the use of near infrared autofluorescence (NIRAF) detection with an FDA-cleared device 'Parathyroid Eye (PTeye)' for identifying parathyroid glands (PGs) during total thyroidectomy (TTx). It compares risk-benefits and outcomes in TTx patients where NIRAF detection with PTeye for parathyroid identification is either used or not used.

NCT ID: NCT04274829 Completed - Thyroid Cancer Clinical Trials

Predictive Factors of Lymph Node Metastasis in Patients With Papillary Microcarcinoma of the Thyroid

Start date: January 2010
Phase:
Study type: Observational

Papillary thyroid microcarcinoma (PTMC), defined as a tumor with larger diameter ≤ 1 cm, is considered a tumor with an indolent course and an excellent prognosis. Nevertheless, the incidence of lymph node metastasis in PTMC is not negligible, reaching up to 65% in some series. The aim of this study was to assess the incidence of lymph node metastasis in patients with PTMC and to evaluate predictive factors for lymph node metastasis.

NCT ID: NCT04248166 Recruiting - Thyroid Cancer Clinical Trials

Thyroid Cancer and Photoacoustic Imaging

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study was to evaluate the usefulness of photoacoustic imaging in thyroid nodules. In addition, we would like to confirm the relationship between the results of photoacoustic imaging and histopathologic findings when thyroid nodules were diagnosed as thyroid cancer.

NCT ID: NCT04238624 Recruiting - Thyroid Cancer Clinical Trials

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

Start date: January 20, 2020
Phase: Phase 2
Study type: Interventional

This study is being done to see if adding the study drug, cemiplimab, to the standard therapy with dabrafenib and trametinib is an effective treatment against anaplastic thyroid cancer.

NCT ID: NCT04224792 Withdrawn - Thyroid Cancer Clinical Trials

Effects of Exercise Training on Fatigue in Thyroid Cancer Survivors

Start date: September 30, 2022
Phase: N/A
Study type: Interventional

Researchers are trying to determine whether an exercise program reduces fatigue and improves physical activity in thyroid cancer patients.